The effects of ritonavir and lopinavir/ritonavir on the pharmacokinetics of a novel CCR5 antagonist, aplaviroc, in healthy subjects

AIMS: This study assessed the effects of the CYP3A inhibitors lopinavir/ritonavir (LPV/r) on the steady-state pharmacokinetics (PK) of aplaviroc (APL), a CYP3A4 substrate, in healthy subjects. METHODS: In Part 1, APL PK was determined in eight subjects who received a single oral 50-mg APL test dose...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adkison, Kimberly K, Shachoy-Clark, Anne, Fang, Lei, Lou, Yu, Otto, Vicky R, Berrey, M Michelle, Piscitelli, Stephen C
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2006
Materias:
Drug Interactions
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885134/
https://ncbi.nlm.nih.gov/pubmed/16934050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02661.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares